51st Annual Meeting of the European Society of Blood and Marrow Transplantation (EBMT 2025)

Topics

• Disease-specific topics
  • Aplastic anaemia
  • Acute leukaemia
  • Chronic leukaemia
  • Autoimmune diseases
  • Lymphoma
  • Haemoglobinopathy and Inborn errors of metabolism
  • Myelodysplasia
  • Multiple myeloma
  • Solid tumours
• General Topics
  • Hematopoietic stem cells
  • Cell therapy
  • Gene Therapy
  • Regenerative medicine
  • Stem cell mobilisation and Graft engineering
  • Non-hematopoietic stem cells
• QUALITY MANAGEMENT GROUP
  • Quality management
  • Accreditation
  • Sharing best practice
  • Regulatory issues
• Transplant-specific topics
  • Stem cell donor
  • Stem cell source
  • Graft-versus-host disease – clinical
  • Graft-versus-host disease – preclinical and animal models
  • Early complications / Late effects & quality of life
  • Infectious complications
  • Minimal residual disease, Tolerance, Chimerism and Immune reconstitution
  • Reduced-intensity conditioning
  • Experimental stem cell transplantation and Tumour stem cells
  • Paediatric issues
• DATA MANAGEMENT GROUP
  • Statistics
  • Data Management